The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

"We believe it could take time for 10x to properly orient its Chromium commercial efforts." He has a buy rating on 10x ...

“The power of 10x Genomics' Chromium™ de novo Assembly Solution is that it is a simple process; a ‘cookbook’ library, standard low-cost sequencing, and push button assembly. Our one library yields ...

10x Genomics (NASDAQ:TXG) has built a reputation as a trailblazer in recent years, with cutting-edge single-cell and spatial technologies. The firm's Chromium, Visium and Xenium platforms have ...

Our facility is equipped with state-of-art instruments, including the 10X Genomics Chromium X which enables high-throughput single cell gene expression profiling, 10X Genomics Xenium platform, and the ...

and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Receive News & Ratings for 10x Genomics Daily - Enter your email address below to receive ...

a 10x Genomics Chromium X Controller, a Covaris LE220-plus, Sage Science BluePippin Prep gel system, two Agilent 4200 TapeStations, a Unchined Labs Lunatic UV/Vis spectrometer, an Invitrogen Qubit 2.0 ...

Genomics (TXG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from ...